Clinical Trials Directory

Trials / Completed

CompletedNCT02616471

Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors

Effect of High Cheese Consumption on Metabolic Syndrome Risk Factors in a Metabolically Vulnerable Population

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
168 (actual)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The overall aim of the present research project is to examine whether consumption of high daily amounts of cheese, both high-fat and low-fat, affects risk markers of disease in a study population of men and women with metabolic syndrome risk factors. It will be explored whether high-fat and/or low-fat cheese consumption can be regarded healthy to consume for at-risk populations (assessed by within-group comparisons from baseline values) and if low-fat or non-fat alternatives to high-fat cheese should continue to be recommended (assessed by between-group comparisons). In addition, it will be assessed if cheese consumption affects women and men differently as suggested by observational data. The present research project will examine the health effects of cheese as a food product per se and not as a sum of single nutrients, knowing that the single components of cheese cannot be adequately placebo-matched. A relatively high daily intake of high-fat cheese will be compared to a similar intake of low-fat cheese and with a carbohydrate control.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh-fat cheese
DIETARY_SUPPLEMENTLow-fat cheese
DIETARY_SUPPLEMENTNo-cheese/carbohydrate

Timeline

Start date
2014-02-01
Primary completion
2015-05-01
Completion
2015-05-01
First posted
2015-11-30
Last updated
2018-08-31

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02616471. Inclusion in this directory is not an endorsement.